Integrator Complex Subunit 6 Regulates Biological Nature of Hepatocellular Carcinoma by Modulating Epithelial–Mesenchymal Transition
Current Issues in Molecular Biology · 09.09.2025 · 47 (9) · 733
DOI: 10.3390/cimb47090733 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Issues in Molecular Biology, online erschienen am 09.09.2025. Verfasst von Sayaka Yonezawa und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Internal Medicine, Hiroshima University Hospital, 1-2-3 Kasumi, Minami-ku, Hiroshima 734-8551, Japan. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Tsuchiya Memorial Medical Foundation, Tsuchiya Memorial Medical Foundation.
Abstract (Originalsprache)
Hepatocellular carcinoma (HCC) is a leading cause of cancer-related death worldwide, with limited therapeutic options and frequent resistance to treatment. The integrator complex subunit 6 (INTS6), a regulator of RNA polymerase II transcription, has emerged as a potential tumor suppressor that modulates Wnt/β-catenin signaling and epithelial–mesenchymal transition (EMT). This study aimed to clarify the role of INTS6 in EMT regulation in HCC and to explore the therapeutic potential of small activating RNA (saRNA)-mediated INTS6 induction. The Cancer Genome Atlas (TCGA) dataset was analyzed to assess the clinical relevance of INTS6 in HCC. Functional studies were conducted using a hepatoma cell line to determine the effects of INTS6 modulation on tumor behavior. Data analysis demonstrated that low INTS6 expression was associated with shorter disease-free survival and poorer prognosis in patients receiving conservative treatment. Experimental suppression of INTS6 increased mesenchymal marker expression, whereas saRNA-mediated induction suppressed these markers. Restoring INTS6 expression reduced cell migration, invasion, and proliferation through G1 cell-cycle arrest and enhanced sensitivity to sorafenib. These findings identify INTS6 as a promising therapeutic target in HCC. saRNA-mediated induction of INTS6 may provide a novel strategy, alone or in combination therapy, to overcome drug resistance and improve clinical outcomes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of General Internal Medicine, Hiroshima University Hospital, 1-2-3 Kasumi, Minami-ku, Hiroshima 734-8551, Japan.
- Department of Probiotic Science for Preventive Medicine, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima 734-8551, Japan.
ORCID-Profile: Keishi Kanno, Masanori Ito
Förderung
- The Tsuchiya Memorial Medical Foundation
- Tsuchiya Memorial Medical Foundation
Zitieren
APA
Yonezawa, S., Kanno, K., Shiozaki, M., Sugiyama, M., & Ito, M. (2025). Integrator Complex Subunit 6 Regulates Biological Nature of Hepatocellular Carcinoma by Modulating Epithelial–Mesenchymal Transition. Current Issues in Molecular Biology, 47(9), 733. https://doi.org/10.3390/cimb47090733
Vancouver
Yonezawa S, Kanno K, Shiozaki M, Sugiyama M, Ito M. Integrator Complex Subunit 6 Regulates Biological Nature of Hepatocellular Carcinoma by Modulating Epithelial–Mesenchymal Transition. Current Issues in Molecular Biology. 2025;47(9):733. doi:10.3390/cimb47090733
BibTeX
@article{Yonezawa2025,
author = {Yonezawa, Sayaka and Kanno, Keishi and Shiozaki, Minami and Sugiyama, Masanori and Ito, Masanori},
title = {Integrator Complex Subunit 6 Regulates Biological Nature of Hepatocellular Carcinoma by Modulating Epithelial–Mesenchymal Transition},
journal = {Current Issues in Molecular Biology},
year = {2025},
volume = {47},
number = {9},
pages = {733},
doi = {10.3390/cimb47090733}
}
EUVIMED